논문 상세보기

구강 편평상피세포암에서 암줄기세포 표지자의 생물학적 역할, 예후적 의의 및 치료적 가능성 KCI 등재

Biological Roles, Prognostic Significance, and Therapeutic Potential of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma: A Narrative Review

김나희, 함주희, 임회순, 정진, Wang Weiyi, 김옥준
  • 언어KOR
  • URLhttps://db.koreascholar.com/Article/Detail/453869
구독 기관 인증 시 무료 이용이 가능합니다. 5,100원
대한구강악안면병리학회지 (The Korean Journal of Oral and Maxillofacial Pathology)
대한구강악안면병리학회 (Korean Academy Of Oral And Maxillofacial Pathology)
초록

Oral squamous cell carcinoma (OSCC) is characterized by marked intratumoral heterogeneity, frequent recurrence, and variable responses to treatment. Cancer stem cells (CSCs) are thought to contribute to these features through their capacity for self-renewal, tumor initiation, phenotypic plasticity, and resistance to therapy. This narrative review summarizes the biological and clinical significance of major CSC-associated markers in OSCC, with a focus on ALDH1, CD44, CD133, SOX2, OCT4, and NANOG. Current evidence suggests that CSC phenotypes are dynamically regulated by epithelial–mesenchymal plasticity, hypoxia, the tumor microenvironment, and signaling pathways including Wnt/β-catenin, Notch, Hedgehog, PI3K/AKT/mTOR, Hippo-YAP/TAZ, and TGF-β. The expression of these markers has been associated with tumor initiation, invasion, metastasis, recurrence, treatment resistance, and patient survival. However, their prognostic significance remains inconsistent across studies because of tumor heterogeneity, limited marker specificity, differences in isoforms and assay methods, and variability in scoring systems and cut-off values. Consequently, no single CSC marker is currently adequate for routine clinical use. Importantly, most CSC-targeted therapeutic strategies remain supported primarily by in vitro and animal studies, and their clinical efficacy in patients with OSCC has not yet been established. Future approaches integrating multi-marker panels with spatially resolved analyses, single-cell and spatial omics, patient-derived models, and liquid biopsy may improve risk stratification and treatment selection. Prospective multicenter validation and methodological standardization are required before CSC-based biomarkers and therapeutic strategies can be incorporated into precision oncology for OSCC.

키워드
Oral squamous cell carcinomaCancer stem cellsCSC markersTreatment resistancePrognosisPrecision oncology
목차

Ⅰ. 서 론
Ⅱ. 연구 방법
Ⅲ. OSCC에서 암줄기세포의 생물학적 특성
Ⅳ. OSCC에서 주요 CSC 표지자
    1. ALDH1
    2. CD44
    3. CD133
    4. SOX2
    5. OCT4
    6. NANOG
Ⅴ. CSC 표지자와 OSCC의 발생 및 진행
Ⅵ. CSC 표지자와 OSCC의 예후
Ⅶ. CSC 표지자와 치료 반응
Ⅷ. CSC 표지자 연구의 한계
Ⅸ. 향후 연구 방향
Ⅹ. 결 론
ACKNOWLEDGEMENTS
REFERENCES
저자
  • 임회순(전남대학교 치의학전문대학원 치의학교육학교실) | Hoi-Soon Lim (Department of Dental Education, School of Dentistry, Chonnam National University)
  • 정진(전남대학교 치의학전문대학원 구강미생물학교실) | Jin Chung (Department of Oral Microbiology, School of Dentistry, Chonnam National University)
  • 김나희(전남대학교 치의학전문대학원 구강병리학교실, 나주대학교 치위생과) | Nahee Kim (Department of Oral Pathology, School of Dentistry, Chonnam National University, Department of Dental Hygiene, Naju College)
  • 함주희(전남대학교 치의학전문대학원 구강병리학교실) | Juhee Ham (Department of Oral Pathology, School of Dentistry, Chonnam National University)
  • Wang Weiyi(전남대학교 치의학전문대학원 구강병리학교실) | Weiyi Wang (Department of Oral Pathology, School of Dentistry, Chonnam National University)
  • 김옥준(전남대학교 치의학전문대학원 구강병리학교실) | Okjoon Kim (Department of Oral Pathology, School of Dentistry, Chonnam National University) Corresponding author